Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Pharma & Drugs
Share your love
The Biggest Challenges in Ophthalmology Today
A recent survey conducted by OBN on LinkedIn asked participants to identify the most pressing challenge facing the ophthalmology field today. The poll revealed that nearly half of the respondents believe patient access to care is the primary issue, followed…
Micro Labs Launches World’s First Triple-Drug for Glaucoma
Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…
Global Pharma Healthcare Recalls EzriCare Eye Drops
Global Pharma Healthcare is recalling its Artificial Tears Lubricant Eye Drops due to potential contamination. The recall affects all lots within expiry and covers products distributed by EzriCare LLC and Delsam Pharma. This comes after the CDC informed the FDA…
FDA Warns of Delsam Pharma’s Artificial Eye Ointment
The FDA has issued a warning to consumers and healthcare professionals not to purchase or use Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination. This eye oinment is an over-the-counter product, intended to be sterile and produced by…
Common Eye Conditions – Names of Eye Diseases List
In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…
Novo Nordisk Weight Loss Drugs Linked to Higher NAION Risk
A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…
Fenofibrate Reduces Diabetic Retinopathy Risk by 27%
In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…
Mediwhale Secures $12M for AI Retina Diagnostics
Mediwhale, an AI-driven diagnostics company, has successfully raised $12 million in Series A2 funding to further develop its retina scanning technology aimed at diagnosing cardiovascular and metabolic diseases. This round was led by the Korea Development Bank, with contributions from…
Pine Pharmaceuticals Announces Recalls, Including Avastin
In response to a recent inspection by the U.S. FDA, Pine Pharmaceuticals has issued two voluntary recalls, including repackaged Avastin and other ocular use products. The company emphasizes that there have been no reported adverse events associated with the impacted…
World’s First Corneal Esthesiometer Approved by the FDA
Brill Engines, a subsidiary of Brill Pharma, specializing in pioneering medical solutions for ophthalmology, announced the FDA approval of its groundbreaking medical device, the Corneal Esthesiometer Brill (CEB). This approval marks a significant milestone in the field of ophthalmology, as…